AR017198A1 - Proceso para la preparacion de isopropil-metil-[2-(3-n-propoxifenoxi)etil]amina, formulaciones farmaceuticas de la misma e intermediarios para uso endicho proceso. - Google Patents

Proceso para la preparacion de isopropil-metil-[2-(3-n-propoxifenoxi)etil]amina, formulaciones farmaceuticas de la misma e intermediarios para uso endicho proceso.

Info

Publication number
AR017198A1
AR017198A1 ARP980106239A ARP980106239A AR017198A1 AR 017198 A1 AR017198 A1 AR 017198A1 AR P980106239 A ARP980106239 A AR P980106239A AR P980106239 A ARP980106239 A AR P980106239A AR 017198 A1 AR017198 A1 AR 017198A1
Authority
AR
Argentina
Prior art keywords
methyl
preparation
propoxifenoxi
endicho
isopropil
Prior art date
Application number
ARP980106239A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR017198A1 publication Critical patent/AR017198A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Proceso para la síntesis de isopropil-metil[2-(3-N-propoxifenoxi)etil]amina. Además, intermediario y con un paso de purificacion optativo incluido en dichoproceso. Por anadidura, la elaboracion de una preparacion farmacéutica que contieneisopropil-m etil[2(3-N-propoxifenoxi)etil]amina y con el uso de isopropil-metil[2-(3-N-propoxifenoxi)etil]amina en medicina. Dicho compuesto es conocido por sus propiedades anestésicas y por consiguiente util para el tratamiento deldolor, incluso eldolor locali zado, y especialmente sobre piel intacta.
ARP980106239A 1997-12-22 1998-12-09 Proceso para la preparacion de isopropil-metil-[2-(3-n-propoxifenoxi)etil]amina, formulaciones farmaceuticas de la misma e intermediarios para uso endicho proceso. AR017198A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704834A SE9704834D0 (sv) 1997-12-22 1997-12-22 New process

Publications (1)

Publication Number Publication Date
AR017198A1 true AR017198A1 (es) 2001-08-22

Family

ID=20409537

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980106239A AR017198A1 (es) 1997-12-22 1998-12-09 Proceso para la preparacion de isopropil-metil-[2-(3-n-propoxifenoxi)etil]amina, formulaciones farmaceuticas de la misma e intermediarios para uso endicho proceso.

Country Status (21)

Country Link
EP (1) EP1045826A1 (es)
JP (1) JP2001526253A (es)
KR (1) KR20010024790A (es)
CN (1) CN1283177A (es)
AR (1) AR017198A1 (es)
AU (1) AU1989199A (es)
BR (1) BR9814377A (es)
CA (1) CA2314988A1 (es)
EE (1) EE200000369A (es)
HU (1) HUP0100616A2 (es)
ID (1) ID27591A (es)
IL (1) IL136825A0 (es)
IS (1) IS5523A (es)
NO (1) NO20002944L (es)
PL (1) PL341438A1 (es)
SE (1) SE9704834D0 (es)
SK (1) SK8052000A3 (es)
TR (1) TR200001976T2 (es)
TW (1) TW436474B (es)
WO (1) WO1999032430A1 (es)
ZA (1) ZA9811238B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103702964A (zh) * 2011-05-26 2014-04-02 索尔维特殊聚合物意大利有限公司 氢氟化合物
JP6247992B2 (ja) * 2014-04-17 2017-12-13 株式会社ダイセル ハロゲン化合物の製造方法
JP6635999B2 (ja) * 2017-10-13 2020-01-29 株式会社ダイセル カリウム塩の製造方法、及びカリウム塩

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL90704A (en) * 1989-06-21 1994-10-07 Makhteshim Chem Works Ltd Method for the preparation of N-N-) 2,4,6-trichlorophenoxy (environmentally reliable ethylene)
AR004691A1 (es) * 1995-10-27 1999-03-10 Astrazeneca Ab Nuevos derivados de [3-alcoxi-fenoxi-)-etil]-dialquilamina, una composicion farmaceutica que los comprende, su uso como anestesicos locales y unprocedimiento para su preparacion

Also Published As

Publication number Publication date
BR9814377A (pt) 2000-10-10
TR200001976T2 (tr) 2000-11-21
CN1283177A (zh) 2001-02-07
EE200000369A (et) 2001-12-17
EP1045826A1 (en) 2000-10-25
NO20002944D0 (no) 2000-06-08
HUP0100616A2 (hu) 2002-05-29
SE9704834D0 (sv) 1997-12-22
IL136825A0 (en) 2001-06-14
SK8052000A3 (en) 2001-02-12
NO20002944L (no) 2000-06-08
JP2001526253A (ja) 2001-12-18
TW436474B (en) 2001-05-28
KR20010024790A (ko) 2001-03-26
ID27591A (id) 2001-04-12
WO1999032430A1 (en) 1999-07-01
PL341438A1 (en) 2001-04-09
CA2314988A1 (en) 1999-07-01
ZA9811238B (en) 1999-06-22
IS5523A (is) 2000-06-07
AU1989199A (en) 1999-07-12

Similar Documents

Publication Publication Date Title
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
CY1108587T1 (el) Φαρμακευτικη συνθεση για τροποποιημενη απελευθερωση ενος ευαισθητοποιητη ινσουλινης και μετφορμινης
ES2090713T3 (es) Sales organicas de n,n'-diacetil-cistina.
CL2009001279A1 (es) Compuestos derivados de nociceptina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor (sol. divisional 2103-03).
BR9501770A (pt) Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
ATE173923T1 (de) Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure
BR0009524A (pt) Uso de um composto, e, composição farmacêutica ou veterinaria
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
BR9915215A (pt) Composição farmacêutica para liberação modificada de sensibilizador de insulina
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
FI962550A0 (fi) Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa
BR0109893A (pt) Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente
BR9602025A (pt) Composto composição farmacêutica uso e processo para a preparação de um composto
PT92649A (pt) Processo para a preparacao do 4-fluoro-2-< { (4-metoxi-2-piridinil)-metil}-sulfinil>-1h-benzimidazol e de composicoes farmaceuticas que o contem
BR9814495A (pt) Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
AR017198A1 (es) Proceso para la preparacion de isopropil-metil-[2-(3-n-propoxifenoxi)etil]amina, formulaciones farmaceuticas de la misma e intermediarios para uso endicho proceso.
BR9508021A (pt) Composição farmacêutica para o tratamento de distúrbios esquizofrênicos, uso de um agente imunossupressor, e, processo de tratamento de um paciente esquizofrênico
BR9812404A (pt) Combinação de um antagonista de endotelina, preparação farmacêutica, processo para preparar uma preparação farmacêutica, e , uso de uma combinação de um bloqueador de beta receptor e de um antagonista de endotelina
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
CL2004001291A1 (es) Composicion farmaceutica que comprende compuestos carbociclicos y heterociclicos; y su uso para el tratamiento o profilaxis de la infeccion por influenza.
PT83253B (pt) Processo para a preparacao de p-acilaminobenzamidas
SE9604752D0 (sv) Formulation and use

Legal Events

Date Code Title Description
FA Abandonment or withdrawal